LAPOROSCOPIC PELVIC EXENTERATION FOR TREATMENT OF PRIMARY MULTIPLE CANCER. CASE REPORT-Reference-Cited by-同舟云学术

LAPOROSCOPIC PELVIC EXENTERATION FOR TREATMENT OF PRIMARY MULTIPLE CANCER. CASE REPORT

Published:2021-10-22 Issue:3 Volume: Page:31-39
ISSN:2223-2427
Container-title:Surgical practice
language:
Short-container-title:jour

Author:

Gallyamov E. A.¹^ORCID,Sanzharov A. E.²^ORCID,Agapov M. A.³^ORCID,Prokhorenko K. A.²^ORCID,Gololobov G. Yu.⁴^ORCID,Doronchyk D. N.²,Daynego V. G.²

Affiliation:

1. Sechenov University; Federal Scientific and Clinical Center for Specialized Methods of Medical Aid and Medical Technologies FMBA; Federal State Budget Educational Institution of Higher Education M.V. Lomonosov Moscow State University (Lomonosov MSU)

2. Federal Scientific and Clinical Center for Specialized Methods of Medical Aid and Medical Technologies FMBA

3. Federal State Budget Educational Institution of Higher Education M.V. Lomonosov Moscow State University (Lomonosov MSU)

4. Sechenov University; City Clinical Hospital named S.I. Spasokykockiy DHM

Abstract

This clinical case represents the experience of surgical treatment of a patient with multiple primary metachronous cancer: 1. Sigmoid cancer рТ4NxM0. Resection of sigmoid colon (16.12.2013). Three courses of adjuvant chemotherapy (XELOX). Recurrence (2015). Laparotomy, Colproctectomy with D3 paraaortic lymph dissection. Ileostomy (2015). One course of chemotherapy (XELOX). 2. Upper tract urothelial carcinoma (right ureter) pT2N0M0R0. Right nephroureterectomy with the resection of the bladder and right testicular cord, cystostomy (19.02.2015). Recurrence. Nephrostomy drainage of the left kidney. Adhesive disease. Rectovesical fistula. Taking into account the history and comorbid status of the patient, it was decided to perform laparoscopic supralevator pelvic exenteration, ureterectomy on the left. The duration of the operation was 280 minutes, intraoperative blood loss was 200 ml. The period of stay in intensive care is 24 hours, the patient was discharged on the 7th day after the operation, the resection margin was negative (R0). After 12 months, there is no data for the disease progressed.

Publisher

Center of Endourology Endocenter

Reference20 articles.

1. Luk'janov A. M., Kicenko Ju. E., Efetov S. K., Fedorov D. N., Tulina I. A., and Car'kov P. V. Mul'tidisciplinarnoe hirurgicheskoe lechenie pervichno-mnozhestvennogo raka tolstoj kishki s sohraneniem estestvennogo hoda kishechnika. Klinicheskaja i jeksperimental'naja hirurgija. vol. 7, no. 2, 2019, pp. 79-84. https://doi.org/10.24411/2308-1198-2019-12011 (In Russ)

2. Ray P, Sharifi R, Ortolano V, Guinan P. Involvement of the genito-urinary system in multiple primary malignant neoplasms: A review. J Clin Oncol. 1983; 1:574-581

3. Kit O.I., Gevorkyan Yu.A., Soldatkina N.V., Kharagezov D.A., Kolesnikov V.E., Milakin A.G. Multiple primary colorectal cancer: the possibilities of minimally invasive surgical interventions. Koloproktologia. 2017;(1):38-42. (In Russ.) https://doi.org/10.33878/2073-7556-2017-0-1-38-42

4. Teplov A.A., Grickevich A.A., Stepanova Ju.A., Miroshkina I.V., P'janikin S.S., Dunaev S.A., Arevin A.G., Morozova M.V.. "Pervichno-mnozhestvennyj rak perehodnokletochnogo jepitelija: diagnostika i osobennosti techenija zabolevanija" Jeksperimental'naja i klinicheskaja urologija, no. 4, 2018, pp. 22-29. (In Russ)

5. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018;68(6):394–424. https://doi.org/10.3322/caac.21492